Beta Bionics plans USD 125 million common stock offering

PUBT · 1d ago
Beta Bionics plans USD 125 million common stock offering
  • Beta Bionics launched an underwritten public offering of USD 125 million of common stock.
  • Deal includes a 30-day underwriters’ option to buy up to an additional USD 18.75 million of common shares.
  • Proceeds earmarked for general corporate purposes, including Mint commercialization, manufacturing expansion, R&D, clinical development, and working capital.
  • J.P. Morgan, Piper Sandler, Wells Fargo Securities, and Leerink Partners are joint book-running managers.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beta Bionics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609151613PRIMZONEFULLFEED9827607) on September 15, 2026, and is solely responsible for the information contained therein.